VIALE, GIUSEPPE
VIALE, GIUSEPPE
Dipartimento di Oncologia ed Emato-Oncologia
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
2024 F. Conforti, L. Pala, T. De Pas, E. Zattarin, C. Catania, E. Cocorocchio, G. Rossi, D. Laszlo, M. Colleoni, A. Zambelli, G.N. Hortobagyi, J. Cortes, M.J. Piccart, M. Dowsett, R.D. Gelber, G. Viale
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
2023 C. Pescia, E. Guerini-Rocco, G. Viale, N. Fusco
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
2023 E. Sajjadi, K. Venetis, M. Ivanova, M. Noale, C. Blundo, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, P. Veronesi, V.E. Galimberti, G. Viale, F.A. Peccatori, N. Fusco, E. Guerini-Rocco
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)
2023 L. Ferrando, A. Vingiani, A. Garuti, C. Vernieri, A. Belfiore, L. Agnelli, G. Dagrada, D. Ivanoiu, G. Bonizzi, E. Munzone, L. Lippolis, M. Dameri, F. Ravera, M. Colleoni, G. Viale, L. Magnani, A. Ballestrero, G. Zoppoli, G. Pruneri
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial
2023 D. Serrano, S. Gandini, P. Thomas, K.D. Crew, N.B. Kumar, L.A. Vornik, J.J. Lee, P. Veronesi, G. Viale, A. Guerrieri-Gonzaga, M. Lazzeroni, H. Johansson, M. D'Amico, F. Guasone, S. Spinaci, B. Bertelsen, G. Mellgren, I. Bedrosian, D. Weber, T. Castile, E. Dimond, B.M. Heckman-Stoddard, E. Szabo, P.H. Brown, A. Decensi, B. Bonanni
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread
2023 C. Criscitiello, C. Corti, M. De Laurentiis, G. Bianchini, B. Pistilli, S. Cinieri, L. Castellan, G. Arpino, P. Conte, F. DI MECO, A. Gennari, V. Guarneri, L. Visani, L. Livi, P. Marchetti, F. Puglisi, G. Viale, L. Del Mastro, S. De Placido, G. Curigliano
TMEM123 a key player in immune surveillance of colorectal cancer
2023 E. Pesce, C. Cordiglieri, M. Bombaci, S. Eppenberger-Castori, S. Oliveto, C. Manara, M. Crosti, C. Ercan, M. Coto, A. Gobbini, S. Campagnoli, T. Donnarumma, M. Martinelli, V. Bevilacqua, E. De Camilli, P. Gruarin, M.L. Sarnicola, E. Cassinotti, L. Baldari, G. Viale, S. Biffo, S. Abrignani, L.M. Terracciano, R. Grifantini
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer
2022 K. Venetis, F. Pepe, E. Munzone, E. Sajjadi, G. Russo, P. Pisapia, M. Ivanova, G. Bonizzi, D. Vacirca, A. Rappa, A. Ranghiero, S.V. Taormina, G. Viale, G. Troncone, M. Barberis, E. Guerini-Rocco, U. Malapelle, N. Fusco
Standard operating procedures for biobank in oncology
2022 G. Bonizzi, L. Zattoni, M. Capra, C. Cassi, G. Taliento, M. Ivanova, E. Guerini-Rocco, M. Fumagalli, M. Monturano, A. Albini, G. Viale, R. Orecchia, N. Fusco
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy
2022 S. Pece, I. Sestak, F. Montani, M. Tillhon, P. Maisonneuve, S. Freddi, K. Chu, M. Colleoni, P. Veronesi, D. Disalvatore, G. Viale, R. Buus, J. Cuzick, M. Dowsett, P.P. Di Fiore
Pathology after neoadjuvant treatment – How to assess residual disease
2022 G. Viale, N. Fusco
Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status
2022 J. Rüschoff, M. Friedrich, I. Nagelmeier, M. Kirchner, L.M. Andresen, K. Salomon, B. Portier, S.T. Sredni, H.U. Schildhaus, B. Jasani, M. Grzelinski, G. Viale
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
2022 G. Bonizzi, M. Capra, C. Cassi, G. Taliento, O. Pala, E. Sajjadi, K. Venetis, M. Ivanova, M. Monturano, G. Renne, L. Zattoni, E. Guerini-Rocco, G. Viale, R. Orecchia, N. Fusco
Sex and cancer immunotherapy: Current understanding and challenges
2022 L. Pala, T. De Pas, C. Catania, G. Giaccone, A. Mantovani, S. Minucci, G. Viale, R.D. Gelber, F. Conforti
Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130
2022 S.S. Badve, F. Penault-Llorca, J.S. Reis-Filho, R. Deurloo, K.P. Siziopikou, C. D'Arrigo, G. Viale
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis
2022 N. Bianco, M. Milano, E. Pagan, C. Oriecuia, V. Bagnardi, E.G. Rocco, G.I. Santomauro, G. Peruzzotti, M. Colleoni, G. Viale
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review
2022 M. Garutti, G. Griguolo, A. Botticelli, G. Buzzatti, C. De Angelis, L. Gerratana, C. Molinelli, V. Adamo, G. Bianchini, L. Biganzoli, G. Curigliano, M. De Laurentiis, A. Fabi, A. Frassoldati, A. Gennari, C. Marchiò, F. Perrone, G. Viale, C. Zamagni, A. Zambelli, L. Del Mastro, S. De Placido, V. Guarneri, P. Marchetti, F. Puglisi
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
2022 N. Fusco, E. Sajjadi, K. Venetis, M. Ivanova, S. Andaloro, E. Guerini-Rocco, E. Montagna, P. Caldarella, P. Veronesi, M. Colleoni, G. Viale
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients
2022 E. Montagna, E. Pagan, G. Cancello, C. Sangalli, V. Bagnardi, E. Munzone, E.O. Salè, D. Malengo, M.E. Cazzaniga, M. Negri, G. Peruzzotti, P. Veronesi, G. Viale, M. Colleoni